Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
09/2005
09/09/2005WO2005014585A8 Halogenated quinazolinyl nitrofurans as antibacterial agents
09/09/2005WO2005009373A3 Tyrosine kinase inhibitors
09/09/2005CA2556768A1 Piperidinyl targeting compounds that selectively bind integrins
09/09/2005CA2554439A1 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases
09/09/2005CA2553572A1 Immunosuppressant compounds and compositions
09/08/2005US20050197501 Reacting calcium hydroxide with an ester derivative or protected ester derivative of the statin; rosuvastatin, pitavastatin and atorvastatin, simvastatin and lovastatin
09/08/2005US20050197377 Diarylimidazoles, substituted with another aromatic ring and one or more carboxylic acids, esters or amides, e.g., 3-[5-Benzo[1,3]dioxol-5-yl-4-(2,5-dichloro-phenyl)-1H-imidazol-2-yl]-2-(3-chloro-phenyl)-acrylic acid; treatment of conditions such as pain, drug dependence, and psychological disorders
09/08/2005US20050197375 Use of benzimidazole analogs in the treatment of cell proliferation
09/08/2005US20050197371 Urea derivatives as PDGFR modulators
09/08/2005US20050197364 Amide compounds as ion channel ligands and uses thereof
09/08/2005US20050197350 Melanin Concentrating Hormone (MCH) receptor antagonist; clinical obesity; eating disorders; N-(cis-4-{[4-(dimethylamino)quinolin-2-yl]amino}cyclohexyl)-3-methoxy-benzamide; N-(2-chlorobenzyl)-N'-(cis-4-{[4- -(dimethylamino)-5,6,7,8-tetrahydroquinazolin-2-yl]amino}cyclohexyl)urea; pyrimidine analogs
09/08/2005US20050197338 Substituted pyrazole urea compounds for the treatment of inflammation
09/08/2005US20050197331 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/08/2005US20050196554 Ink-receiving layer with light-fastness and photostability
09/07/2005EP1571150A1 Process for the preparation of tryptase inhibitors
09/07/2005EP1571146A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
09/07/2005EP1571145A1 Substituted piperidine compounds for use as H3 histamine receptor antagonists
09/07/2005EP1571142A1 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/07/2005EP1570846A1 The novel coumarin-amide derivatives and its preparation, said drug composition and its use
09/07/2005EP1569934A2 Cyclopropyl compounds as ccr5 antagonists
09/07/2005EP1569932A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
09/07/2005EP1569926A1 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
09/07/2005EP1569925A1 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
09/07/2005EP1569919A2 Non-nucleoside reverse transcriptase inhibitors
09/07/2005EP1569917A1 Pyrazine-based tubulin inhibitors
09/07/2005EP1569916A1 Substituted aralkyl derivatives
09/07/2005EP1569910A2 Pesticidal sulphonylaminopyrazoles
09/07/2005EP1569908A2 Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors
09/07/2005EP1569907A1 Nicotinamide-based kinase inhibitors
09/07/2005EP1569905A2 Inhibitors of monoamine uptake
09/07/2005EP1569901A2 ARYL, ARYLOXY, AND ALKYLOXY SUBSTITUTED i 1H /i -INDOL-3-YL GLYOXYLIC ACID DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
09/07/2005EP1569658A2 Treatment of ebv and khsv infection and associated abnormal cellular proliferation
09/07/2005EP1569653A1 Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k
09/07/2005EP1569652A2 N sp 4 /sp-acylcytosine nucleosides for treatment of viral iinfections
09/07/2005EP1569637A1 Bicyclic-substituted amines as histamine-3 receptor ligands
09/07/2005EP1368342B1 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
09/07/2005EP1347957B1 Delta 1-pyrrolines used as pesticides
09/07/2005EP1333824B1 Treatment of sexual dysfunction with bombesin receptor antagonists
09/07/2005EP1192132B1 Serine protease inhibitors
09/07/2005EP1189893B1 Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)one
09/07/2005EP1188747B1 Phenoxypropylamine compounds
09/07/2005EP1104291B1 Pellets having a core coated with an antifungal and a polymer
09/07/2005EP1095028B1 Substituted acylamino phenyl uracils
09/07/2005EP1042295B1 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
09/07/2005CN1665807A Novel physiolgically active substances
09/07/2005CN1665806A Medicine compound
09/07/2005CN1665792A Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses
09/07/2005CN1665791A Quinazoline derivatives
09/07/2005CN1665789A Diaminopyrimidinecarboxa mide derivative
09/07/2005CN1665787A Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
09/07/2005CN1665785A 2-cyano-4-fluoropyrrolidine derivative or its salt
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1665506A 2, 5-substituted pyrimidine derivatives as CCR-3 receptor antagonists IX
09/07/2005CN1665502A MCHIR antagonists
09/07/2005CN1217936C Heterocyclic compounds having sulfonamide
09/07/2005CN1217932C Antibacterial agents
09/07/2005CN1217659C Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
09/06/2005US6939985 covalently coupling organic compounds by reacting an aromatic ring compound having a halogen or halogen-like substituent at a coupling position with a diboron derivative in the presence of a Group VIII metal catalyst and a base
09/06/2005US6939887 Nitrogen compounds such as 3-[2-(diethylamino)ethyl]-1-(2-methylbenzyl)-2-oxo-7-(trifluoromethyl)-2,3-dihydro-1H-benzimidazole-5-carboxamide trifluoroacetate, used as somatoliberins
09/06/2005US6939883 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
09/06/2005US6939882 Fungicides
09/06/2005US6939875 Carbocyclic oxy sulfides such as [4-(Biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid, used to control peroxisome proliferator activated receptors (PPAR), for prophylaxis of metabolic disorders
09/06/2005US6939874 Substituted pyrimidinyl derivatives and methods of use
09/06/2005US6939872 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
09/06/2005US6939867 Phenyl sulfamide derivatives as dietetics, antidiabetics, and hypotensive agents
09/06/2005US6939866 Antitumor agents; skin disorders; anticancer agents
09/06/2005US6939532 Versatile hydrophilic dyes
09/06/2005CA2086137C Benzofuranylimidazole derivatives, a process for the preparation and therapeutical compositions containing the same
09/01/2005WO2005080388A1 Viral polymerase inhibitors
09/01/2005WO2005080383A1 Itraconazole hydrochloride, the preparation and the oral solid composition thereof
09/01/2005WO2005080382A1 Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
09/01/2005WO2005080378A1 Fused pyridazine derivatives
09/01/2005WO2005080377A1 COMPOUND HAVING TGF-β INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
09/01/2005WO2005080372A1 Dihydropyridinone derivatives
09/01/2005WO2005080371A1 Amino heterocyclic modulators of chemokine receptor activity
09/01/2005WO2005080367A1 Ep2 receptor agonists
09/01/2005WO2005080363A1 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
09/01/2005WO2005080360A1 Compounds
09/01/2005WO2005080354A1 1,2,4-triazines derivatives, preparation thereof and use thereof in human therapeutics
09/01/2005WO2005080352A2 Quinazoline derivatives and therapeutic use thereof
09/01/2005WO2005080343A2 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators
09/01/2005WO2005080342A1 Pyridine derivatives and their use as cb2 receptor modulators
09/01/2005WO2005080317A2 Therapeutic amide derivatives
09/01/2005WO2005079802A1 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
09/01/2005WO2005079801A1 Pyrimidine compounds as purine receptor antagonist
09/01/2005WO2005079800A1 Pyrimidine compounds as purine receptor antagonist
09/01/2005WO2005042533A3 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors
09/01/2005WO2005037271A3 Large conductance calcium-activated k channel opener
09/01/2005WO2003101941A3 Alpha acyloxyacetamides for kallikrein and urokinase inhibition
09/01/2005US20050192411 Triazine compounds, polymers comprising triazine structural units, and method
09/01/2005US20050192339 Compounds
09/01/2005US20050192331 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
09/01/2005US20050192314 Use of urea derivatives of isoxazoles; c-kit kinase inhibitors; anticancer agents; leukemias such as acute myelogenous leukemia (AML), and chronic myelogenous leukemias (CMLs)
09/01/2005US20050192304 Rho-kinase inhibitors
09/01/2005US20050192297 melanocortin-4 receptor (MC4-R) agonists; antidiabetic agents; non-insulin dependent diabetes; obesity
09/01/2005US20050192294 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
09/01/2005US20050192293 Vanilloid receptor VR1 modulators; pain, inflammation, traumatic injury, autoimmune disease; compounds are pyridine subsituted at 2 position with an amido-, sulfoamido- or thioamide-substituted (N-hetero)aryl ring
09/01/2005US20050192292 Pyrrolidone carboxamides
09/01/2005US20050192291 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
09/01/2005US20050192287 Substituted benzazoles and methods of their use as inhibitors of Raf kinase
1 ... 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 ... 694